WebMar 19, 2013 · High potency statin treatment was defined as ≥10 mg rosuvastatin, ≥20 mg atorvastatin, and ≥40 mg simvastatin; all other statin treatments were defined as low potency. Statin potency groups were further divided into cohorts with or without chronic kidney disease. Main outcome measure Relative hospitalization rates for acute kidney … WebJan 19, 2024 · Currently, experts recommend high intensity statins for four groups of people: 1) Those who have athersclerotic cardiovascular disease ( ASCVD) and are age 75 or …
Statins: Are these cholesterol-lowering drugs right for you?
WebAug 7, 2007 · The 4 statins currently approved for use in FH children by the US Food and Drug Agency (FDA) all with labeling consistent with the recent AHA pediatric statement in terms of age when treatment should be started are lovastatin, simvastatin, pravastatin, and atorvastatin. Between these 4 statins, randomized placebo-controlled trials of at least ... WebA high-intensity statin, defined as the dose at which a reduction in LDL-cholesterol of ... highway 36 quilt shop hop
Use of high potency statins and rates of admission for acute …
Web• Choose dosing for % LDL-C reduction: high-intensity statin (≥ 50%), moderateintensit- y statin (30– 49%). See Table 6-9 for statin “intensity” levels, effects, interactions, and contraindications. • Four main treatment benefit groups and their dosing intensity (Tables 5 and 6). Clinical ASCVD: If age ≤ 75 years, use high-intensity WebMar 18, 2013 · High potency statin treatment was defined as ≥ 10 mg rosuvastatin, ≥ 20 mg atorvastatin, and ≥ 40 mg simvastatin; all other statin treatments were defined as low potency. Statin potency groups were further divided into cohorts with or without chronic kidney disease. Main outcome measure: Relative hospitalization rates for acute kidney … WebLowers LDL-C 30 to < 50%. Clinical ASCVD, age > 75. Diabetes, age 40 to 75, and 10-year ASCVD risk < 7.5%. Age 40 to 75, 10-year ASCVD risk ≥ 7.5% (if unable to tolerate high … highway 365 tx